Filter
66
Filtered Results: 66
Text search:
Covaxin
Featured
Recommendations
8
New Publications
21
Language
Document type
Guidelines
16
Studies & Reports
13
Fact sheets
11
Strategic & Response Plan
7
No document type
7
Situation Updates
3
Online Courses
3
Training Material
2
Brochures
2
Resource Platforms
2
Countries / Regions
Ukraine
4
India
4
China
3
Middle East and North Africa
3
Paraguay
3
Argentina
3
Russia
3
Senegal
2
Burkina Faso
2
Brazil
2
Colombia
1
Rwanda
1
Cameroon
1
Syria
1
Nigeria
1
Niger
1
Mauritania
1
Africa
1
Latin America and the Carribbean
1
Germany
1
Congo, Democratic Republic of
1
Bangladesh
1
South Africa
1
Ethiopia
1
Mali
1
Chad
1
Zambia
1
Authors & Publishers
Publication Years
Category
COVID-19
21
Capacity Building
5
Guidelines
4
Studies & Reports
4
Under-5 nutrition
2
Pediatrics
2
Clinical Training
1
Hepatitis
1
Vaccine-preventable Diseases
1
Policies & Guidelines HIV & TB
1
Policies
1
Women & Child Health
1
Information, Education and Communication (IEC)
1
Humanitarian Crisis
1
Statistics
1
Nutrition
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
10
Immunization Guidelines
7
Access & Strategy
6
COVAX Initiative
6
Covaxin
5
Logistics & Supply
4
Online Courses & Resources
3
For Health Worker
3
Fair Allocation & Ethical Aspects
3
Inactivated COVID-19 Vaccines
3
Child Health / Pediatrics
2
Research & Pipeline
2
Booster Doses
2
Vaccination
1
Adults
1
Pediatrics
1
Children
1
Clinical Guidelines
1
For Parents & Children
1
For Pregnant Women
1
Global Impact: Socio-economic, health services, TB & HIV
1
Scientific & Research Studies
1
Country-specific Platforms
1
Educational Settings
1
Paediatrics
1
Infection Control & Prevention (IPC)
1
Communication Material
1
SARS-CoV-2 Variants
1
Vaccine Hesitancy & Myths
1
Long COVID/ Post-COVID Syndrome
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Essential Medicines
1
Prices and Patents
1
Guidelines & Manuals
1
General
1
General Information
1
General Information & Methodology
1
Global Overview
1
Human Rights & the Right to Health
1
Training
1
Global Health Ethics
1
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h...
Available in English, French, Chinese, Arabic, Russian
8 February 2021
This presentation presents the issues we confront in deciding how to communicate to the public that COVID-19 vaccine recommendations reflect the state of scientific knowledge.
Join the campaign to call on countries and companies to ensure that by the time World Health Day arrives on 7 April, COVID-19 vaccines are being administered in every country, as a symbol of hope for overcoming both the pandemic and the inequalities that lie at the root of so many global health chal...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
11 august 2022, updated version
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br...
2 April 2022
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan...
L’ensemble du personnel de santé qui participe au déploiement et à la mise en œuvre de la vaccination contre la COVID-19 doit avoir les connaissances et les compétences requises pour garantir une administration sûre et efficace du vaccin contre la COVID-19. Ce cours de formation fournit des ...
يحتاج العاملون الصحيون الذين يشاركون في نشر وتنفيذ التطعيم ضد كوفيد-19 إلى معرفة خاصة بكل لقاح لضمان تقديم اللقاحات بشكل آمن وفعال. يوفر هذا التدريب معلومات أساسية ح...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
